Zilovertamab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Zilovertamab, covering 2023-04-21 to 2023-04-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma [Phase 3]